INVO Fertility, Inc. Business Acquisition, Pro Forma Net Income (Loss)
INVO Fertility, Inc. (IVF) reported Business Acquisition, Pro Forma Net Income (Loss) of -$21.54 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2025-04-30
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was -$6.18M, a 1802.99% decline year-over-year.
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was -$998.38K.
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-12-31 was $363.18K.
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-09-30 was -$2.06M.
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for fiscal 2024 was -$21.54M.
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for fiscal 2023 was -$11.31M.
- INVO Fertility, Inc. business acquisition, pro forma net income (loss) for fiscal 2022 was -$9.21M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -$21.54M 10-K · filed 2025-04-30 | ||||
| 2023-12-31 | -$6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | -$7.18M derived: sum of 2 quarters · filed 2025-04-30 | -$11.31M 10-K · filed 2025-04-30 | -$7.12M 10-K · filed 2024-04-16 | |
| 2023-09-30 | -$998.38K 10-Q · filed 2023-11-13 | -$5.13M 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | $363.18K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | -$1.69M derived: sum of 2 quarters · filed 2024-11-19 | -$9.21M 10-K/A · filed 2024-11-19 | ||
| 2022-09-30 | -$2.06M 10-Q · filed 2023-11-13 | -$9.57M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |